Treatment of Minimal Residual Disease in “Poor Risk” Acute Lymphoblastic Leukaemia with High-Dose Cytosine Arabinoside
- 1 January 1986
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid.Journal of Clinical Oncology, 1983
- Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.Journal of Clinical Oncology, 1983
- Treatment Strategy for Different Risk Groups in Childhood Acute Lymphoblastic Leukemia: A Report From the BFM Study GroupPublished by Springer Science and Business Media LLC ,1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958